Regional
Metro Regional EMS
Metro Regional EMS (OR) carries 42 drugs across 158 dose entries in its current published protocol, effective 2026-01-01.
A newer version (dated 2026-01-01) is under review. The figures below are from the current listed document.
Drugs and doses42
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV | not captured | standing | page 35 |
| Fever | adult | 325–1000 mg | PO | not captured | standing | page 35 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 35 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 48 |
| Severe pain | adult | 1000 mg | IV | not captured | standing | page 48 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 51 |
| Other | adult | 50 g | PO | not captured | standing | page 51 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 51 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 51 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 22 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 22 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | page 9 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | page 9 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 56 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 56 |
| COPD | adult | 2.5 mg | NEB | not captured | standing | page 56 |
| Hyperkalemia | peds | 2.5 mg | NEB | not captured | standing | page 36 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 58 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | page 19 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 28 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 25 |
| Narrow-complex tachycardia | peds | 2.5 mg/kg | IV/IO | not captured | standing | page 25 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 22 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 16 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 16 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 28 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 20 |
| Organophosphate poisoning | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 52 |
| Organophosphate poisoning | adult | 3–5 mg | IV/IO/IM | not captured | standing | page 52 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 52 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–3 g | IV/IO | not captured | standing | page 51 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | page 36 |
| Hyperkalemia | peds | 0.6 mL/kg | IV/IO | not captured | standing | page 36 |
| Other | adult | 10% calcium gluconate | NEB | not captured | standing | page 52 |
| Other | adult | 3 g | not captured | not captured | standing | page 52 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | IV/IM/PO | not captured | standing | page 9 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 9 |
| Asthma / bronchospasm | adult | 10 mg | IV/IM/PO | not captured | standing | page 56 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 56 |
| Croup | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 58 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10–25 g | IV/IO | not captured | standing | page 32 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 42 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 32 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | peds | 1 mg/kg | IV/IM | not captured | standing | page 6 |
| Allergic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 9 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 9 |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 7 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 7 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5 mg | IV/IO | not captured | standing | page 5 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 5 |
| Agitation | peds | 0.1 mg/kg | IM | not captured | standing | page 5 |
| Nausea / vomiting | adult | 0.625 mg | IV | not captured | standing | page 41 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 9 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 9 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 56 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 56 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 20 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 20 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 16 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 16 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.15 mg/kg | IV/IO | not captured | standing | page 25 |
| Procedural sedation | peds | 0.15 mg/kg | IV/IO | not captured | standing | page 25 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mcg | IV/IO | not captured | standing | page 15 |
| Severe pain | adult | 50–100 mcg | IV/IM/IN | not captured | standing | page 48 |
| Severe pain | peds | 1 mcg/kg | IV/IM/IN | not captured | standing | page 48 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg | IV/IM | not captured | standing | page 9 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 32 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg | IV/IO/IM | not captured | standing | page 5 |
| Nausea / vomiting | adult | 1.25 mg | IV/IM | not captured | standing | page 41 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.25–0.5 mg | IV | not captured | standing | page 48 |
| Severe pain | adult | 0.5–1 mg | IM | not captured | standing | page 48 |
| Severe pain | peds | 0.01 mg/kg | IV | not captured | standing | page 48 |
| Severe pain | peds | 0.01 mg/kg | IM | not captured | standing | page 48 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 12 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 12 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 200–600 mg | PO | not captured | standing | page 35 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 35 |
| Mild to moderate pain | adult | 200–600 mg | PO | not captured | standing | page 48 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 56 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 56 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 56 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 12.5–25 mg | IV/IO | not captured | standing | page 48 |
| Severe pain | adult | 25–50 mg | IM | not captured | standing | page 48 |
| Severe pain | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 48 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15 mg | IV | not captured | standing | page 48 |
| Severe pain | adult | 30 mg | IM | not captured | standing | page 48 |
| Severe pain | peds | 0.5 mg/kg | IV | not captured | standing | page 48 |
| Severe pain | peds | 1 mg/kg | IM | not captured | standing | page 48 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 10 mg | IV | not captured | standing | page 44 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.75 mg/kg | IV/IO | not captured | standing | page 19 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 16 |
| VF / pulseless VT | peds | Follow adult dose | IV/IO | not captured | standing | page 16 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2 mg | IV/IO | not captured | standing | page 7 |
| Procedural sedation | adult | 2 mg | IM | not captured | standing | page 25 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | page 25 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | page 26 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 26 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 56 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | page 44 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV | not captured | standing | page 44 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 44 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 22 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IO | not captured | standing | page 5 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 5 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 5 |
| Agitation | peds | 0.1 mg/kg | IM | not captured | standing | page 5 |
| Mild to moderate pain | adult | 2.5–5 mg | IV/IO/IM | not captured | standing | page 7 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 20 |
| Procedural sedation | adult | 5 mg | IM/IN | not captured | standing | page 25 |
| Procedural sedation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 25 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | page 60 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 60 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 60 |
| Seizure | peds | 0.3 mg/kg | IM/IN | not captured | standing | page 60 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 2–8 mg | IV | not captured | standing | page 48 |
| Severe pain | adult | 5–10 mg | IM | not captured | standing | page 48 |
| Severe pain | peds | 0.1 mg/kg | IV | not captured | standing | page 48 |
| Severe pain | peds | 0.1 mg/kg | IM | not captured | standing | page 48 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.5 mg | IV | not captured | standing | page 8 |
| Opioid overdose | adult | 2 mg | IM/IN | not captured | standing | page 8 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 8 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 8 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 28 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 55 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 55 |
| CHF / pulmonary edema | adult | 1 mg | IV | not captured | standing | page 55 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 4 mcg | IV | not captured | standing | page 63 |
| Cardiogenic shock | peds | 0.1 mcg/kg | IV | not captured | standing | page 63 |
| Hypotension / shock | adult | 4 mcg | IV | not captured | standing | page 63 |
| Hypotension / shock | adult | 4 mcg | IV | not captured | standing | page 63 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV | not captured | standing | page 63 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV | not captured | standing | page 63 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | ODT | not captured | standing | page 5 |
| Agitation | peds | 2.5–5 mg | ODT | not captured | standing | page 5 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 41 |
| Nausea / vomiting | adult | 4 mg | IM | not captured | standing | page 41 |
| Nausea / vomiting | adult | 8 mg | PO | not captured | standing | page 41 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | page 41 |
| Nausea / vomiting | peds | 0.1 mg/kg | IM | not captured | standing | page 41 |
| Nausea / vomiting | peds | 2 mg | PO | not captured | standing | page 41 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | As directed | PO | not captured | standing | page 32 |
| Hypoglycemia | peds | As directed | PO | not captured | standing | page 32 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 33 |
| Other | peds | 2 spray | IN | not captured | standing | page 33 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 unit | IV/IM | not captured | standing | page 45 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 drop | not captured | not captured | standing | page 34 |
| Mild to moderate pain | adult | 1 drop | not captured | not captured | standing | page 34 |
| Mild to moderate pain | peds | 1 drop | not captured | not captured | standing | page 34 |
| Mild to moderate pain | peds | 1 drop | not captured | not captured | standing | page 34 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | page 36 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 52 |
| Other | adult | 2.5 mL | NEB | not captured | standing | page 52 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 50 mL | IV/IO | not captured | standing | page 12 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 2 g | IV/IO | not captured | standing | page 70 |
| Obstetric hemorrhage | adult | 2 g | IV | not captured | standing | page 45 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 63 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10–20 mg | IM | not captured | standing | page 5 |
| Agitation | peds | 10 mg | IM | not captured | standing | page 5 |